Faculty/Authors Melissa P. Upton, MDDepartment of Pathology, University of Washington, Seattle CME/CMLE Credit: 1.0 Estimated Completion Time: 1 hour Format: Online Educational Activity and Post-Test Physician Competencies: Medical knowledge, patient care, practice-based learning Eligibility for CME/CMLE credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:
Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME or SAMs CME credit.) Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Faculty DisclosuresThe Journal CME editor and faculty have no relevant financial relationships with commercial interests to disclose.
Technical Considerations
Release Date: 3/21/2025 Review Date:Expiration Date: 3/21/2028
Summarize the clinical features that can help to differentiate lymphoplasmacytic lymphoma, nodal marginal zone lymphoma, splenic marginal zone lymphoma, extranodal marginal zone lymphomas (such as in stomach or lung), and plasma cell neoplasm.
Outline a strategy for applying flow cytometry to differentiate the above listed B-cell lymphoproliferative disorders with plasmacytic differentiation, and identify patterns of expression that may be overlapping among these disorders.
List the known genetic alterations, including mutations and translocations, that can assist in the differential diagnosis of B-cell lymphoproliferative disorders with plasmacytic differentiation.